Dipeptidyl Peptidase 4 Inhibitors vs Metformin for New-onset Dementia: A Propensity Score-matched Cohort Study
Si‐Yang Maggie Liu(University of Arizona), Jie Shen(Xinjiang Medical University), Jianping Weng(University of Science and Technology of China), Hua Li(Sir Run Run Shaw Hospital), Guisen Li(China Pharmaceutical University), Yongjun Shi(Huizhou Central People's Hospital), Yan Zha(Guizhou University), Sheng Nie(Nanfang Hospital), Hua Liang(Sun Yat-sen University), Fan Fan Hou(Southern Medical University), Ying Hu(Harbin Institute of Technology), Hongjiang Wu(Chinese University of Hong Kong), Guobin Su(Guangzhou University of Chinese Medicine), Ying Tang(University of California, Irvine Medical Center), Jialu Liu(Guangdong Medical College), Chunbo Chen(Southern University of Science and Technology), Bi‐Cheng Liu(Nanfang Hospital), Mengchun Gong(Nanfang Hospital), Lan Liu(Children's Hospital of Chongqing Medical University), Heng Wan(The First People's Hospital of Shunde), Yaozhong Kong(First People's Hospital of Foshan), Qiongqiong Yang(Sun Yat-sen University), Hong Xu(Children's Hospital of Fudan University), Huanyi Cao(Guangdong Academy of Medical Sciences), Gang Xu(Tongji Hospital), Qijun Wan(Shenzhen Second People's Hospital), Yilun Zhou(Capital Medical University)
Cited by 4
Related Papers
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
|Pharmacological Reviews|2021|1.1k